Is a complete ATRA research report available?

No complete published report is available for Atara Biotherapeutics, Inc. (ATRA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · USD

$8.38

+0.08 (+1.0%)· Recorded snapshot

Market cap	84.1M
Revenue (ttm)	6.2M
Net income (ttm)	-16.7M
EPS (ttm)	-$1.19
Shares out	10M
P/E (forward)	28.8x
Volume	26,074
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.2M
Net income (ttm): -16.7M
EPS (ttm): -$1.19
P/E (forward): 28.8x
Market cap: 84.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Metric	Value
Amount currency	USD
CIK code	0001604464
Company name	Atara Biotherapeutics, Inc.
Country	United States
Country code	US
CUSIP number	046513206
Earnings date	2026-11-11
Earnings time	bmo
Employees	10
Employees change	-28
Employees growth	-73.68%
Enterprise value	$84.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
Industry	Biotechnology
IPO date	2014-10-16
Is primary listing	Yes
Is SPAC	No
ISIN number	US0465132068
Last 10-K release date	2026-03-16
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2024-06-20
Last stock split type	Reverse
Market cap	$84.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	No
Price	$8.38
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	ATRA
U.S. state	California
Website	https://www.atarabio.com

Metric

Value

Amount currency

USD

CIK code

0001604464

Company name

Atara Biotherapeutics, Inc.

Country

United States

Country code

CUSIP number

046513206

Earnings date

2026-11-11

Earnings time

bmo

Employees

Employees change

-28

Employees growth

-73.68%

Enterprise value

$84.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

Industry

Biotechnology

IPO date

2014-10-16

Is primary listing

Yes

Is SPAC

ISIN number

US0465132068

Last 10-K release date

2026-03-16

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2024-06-20

Last stock split type

Reverse

Market cap

$84.1M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Price

$8.38

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

ATRA

U.S. state

California

Website

https://www.atarabio.com

Metric	Value
Earnings yield	-14.19%
EV/Sales	13.45x
FCF / EV yield	-26.28%
FCF yield	-26.28%
Forward EV/Sales	2.46x
Forward P/E	28.81x
Forward P/S	2.46x
P/S ratio	13.45x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-14.19%

EV/Sales

13.45x

FCF / EV yield

-26.28%

FCF yield

-26.28%

Forward EV/Sales

2.46x

Forward P/E

28.81x

Forward P/S

2.46x

P/S ratio

13.45x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-180.59%
EBITDA margin	-178.53%
Gross margin	75.27%
Operating margin	-180.59%
Pretax margin	-268.95%
Profit margin	-269.42%
Profit per employee	$-1.7M
Profitable years	1
Revenue per employee	$619,400
ROA	-24.14%
ROA (5Y)	-26.18%
ROCE	-78.9%
ROIC	-78.42%
SBC / revenue	62.72%
Tax / revenue	0.47%

Metric

Value

EBIT margin

-180.59%

EBITDA margin

-178.53%

Gross margin

75.27%

Operating margin

-180.59%

Pretax margin

-268.95%

Profit margin

-269.42%

Profit per employee

$-1.7M

Profitable years

Revenue per employee

$619,400

ROA

-24.14%

ROA (5Y)

-26.18%

ROCE

-78.9%

ROIC

-78.42%

SBC / revenue

62.72%

Tax / revenue

0.47%

Metric	Value
EPS growth years	2
Gross profit growth	-93.21%
Net income growth years	2
Revenue growth	-96.72%
Revenue growth (Q)	-96.42%
Revenue growth (QoQ)	22.09%
Revenue growth 3Y	-3.36%
Revenue growth 5Y	-3.55%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

-93.21%

Net income growth years

Revenue growth

-96.72%

Revenue growth (Q)

-96.42%

Revenue growth (QoQ)

22.09%

Revenue growth 3Y

-3.36%

Revenue growth 5Y

-3.55%

Revenue growth years

Metric	Value
Depreciation and amortization	$128,000
EBIT	$-11.2M
EBITDA	$-11.1M
EPS	$-1.19
FCF per share	$-2.18
Financing cash flow	$8.8M
Free cash flow	$-21.9M
Free cash flow minus SBC	$-25.8M
Gross profit	$4.7M
Income taxes	$29,000
Investing cash flow	$-607,000
Net cash flow	$-13.7M
Net income	$-16.7M
Operating cash flow minus SBC	$-25.8M
Operating income	$-11.2M
Revenue	$6.2M
Stock-based compensation	$3.9M

Metric

Value

Depreciation and amortization

$128,000

EBIT

$-11.2M

EBITDA

$-11.1M

EPS

$-1.19

FCF per share

$-2.18

Financing cash flow

$8.8M

Free cash flow

$-21.9M

Free cash flow minus SBC

$-25.8M

Gross profit

$4.7M

Income taxes

$29,000

Investing cash flow

$-607,000

Net cash flow

$-13.7M

Net income

$-16.7M

Operating cash flow minus SBC

$-25.8M

Operating income

$-11.2M

Revenue

$6.2M

Stock-based compensation

$3.9M

Metric	Value
Altman Z-Score	-135.53
Book value per share	$-3.92
Interest coverage	-3.96
Long-term assets	$7.5M
Long-term liabilities	$51.2M
Net cash (debt)	$-6,000
Net cash / market cap	-0.01%
Piotroski F-Score	2
Property, plant and equipment	$6.7M
Shareholders' equity	$-37M
Tangible book value	$-37M
Tangible book value per share	$-3.92
Total assets	$21M
Total cash	$9.9M
Total debt	$9.9M
Total liabilities	$58M
WACC	7.27%

Metric

Value

Altman Z-Score

-135.53

Book value per share

$-3.92

Interest coverage

-3.96

Long-term assets

$7.5M

Long-term liabilities

$51.2M

Net cash (debt)

$-6,000

Net cash / market cap

-0.01%

Piotroski F-Score

Property, plant and equipment

$6.7M

Shareholders' equity

$-37M

Tangible book value

$-37M

Tangible book value per share

$-3.92

Total assets

$21M

Total cash

$9.9M

Total debt

$9.9M

Total liabilities

$58M

WACC

7.27%

Metric	Value
Asset turnover	0.21
Current assets	$13.5M
Current liabilities	$6.8M
Current ratio	1.98
Net working capital	$-2.1M
Quick ratio	1.49
Working capital	$6.7M
Working capital turnover	0.73

Metric

Value

Asset turnover

0.21

Current assets

$13.5M

Current liabilities

$6.8M

Current ratio

1.98

Net working capital

$-2.1M

Quick ratio

1.49

Working capital

$6.7M

Working capital turnover

0.73

Metric	Value
Buyback yield / dilution	-36.26%
Dividend yield	0%
Shareholder yield	-36.26%

Metric

Value

Buyback yield / dilution

-36.26%

Dividend yield

Shareholder yield

-36.26%

Metric	Value
10Y price change	-97.53%
10Y return CAGR	-30.93%
10Y total return	-97.53%
150-day SMA	$8.50
1D price change	0.96%
1M price change	-4.54%
1M total return	-4.54%
1W price change	-8.19%
1W total return	-8.19%
1Y price change	-46.06%
1Y return CAGR	-46.08%
1Y total return	-46.06%
20-day SMA	$9.14
200-day SMA	$7.64
3M price change	9.08%
3M total return	9.08%
3Y price change	-73.09%
3Y return CAGR	-35.43%
3Y total return	-73.09%
50-day SMA	$9.24
50-day SMA vs 200-day SMA	50over200
52-week high	$19.15
52-week high date	2026-01-05
52-week low	$3.92
52-week low date	2026-02-23
5Y price change	-97.75%
5Y return CAGR	-53.2%
5Y total return	-97.75%
6M price change	68.54%
6M total return	68.54%
All-time high	$1,639.00
All-time high date	2015-07-14
All-time low	$3.92
All-time low date	2026-02-23
Average true range (ATR)	$0.61
Average volume	32.3K
Beta (1Y)	2.13
Beta (2Y)	0.95
Beta (5Y)	0.22
Change from 52-week high	-56.23%
Change from 52-week low	113.78%
Change from all-time high	-99.49%
Change from all-time low	114.54%
Change from open	-1.99%
Day's gap	3.01%
Dollar volume	$218,500
High price	$8.55
Low price	$8.37
Monthly RSI	39.48
Open price	$8.55
Position in 52-week range	5.56%
Premarket change	0%
Premarket close	$8.30
Premarket price	$8.30
Previous close	$8.30
Price vs 150-day SMA	-1.06%
Price vs 20-day SMA	-7.99%
Price vs 200-day SMA	10.09%
Price vs 50-day SMA	-8.98%
Relative volume	0.81
RSI	40.91
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.4
Sharpe ratio (5Y)	0.03
Sortino ratio	0.41
Sortino ratio (3Y)	0.65
Sortino ratio (5Y)	0.09
Volume	26.1K
Weekly RSI	46.82
YTD price change	-53.51%
YTD total return	-53.51%

Metric

Value

10Y price change

-97.53%

10Y return CAGR

-30.93%

10Y total return

-97.53%

150-day SMA

$8.50

1D price change

0.96%

1M price change

-4.54%

1M total return

-4.54%

1W price change

-8.19%

1W total return

-8.19%

1Y price change

-46.06%

1Y return CAGR

-46.08%

1Y total return

-46.06%

20-day SMA

$9.14

200-day SMA

$7.64

3M price change

9.08%

3M total return

9.08%

3Y price change

-73.09%

3Y return CAGR

-35.43%

3Y total return

-73.09%

50-day SMA

$9.24

50-day SMA vs 200-day SMA

50over200

52-week high

$19.15

52-week high date

2026-01-05

52-week low

$3.92

52-week low date

2026-02-23

5Y price change

-97.75%

5Y return CAGR

-53.2%

5Y total return

-97.75%

6M price change

68.54%

6M total return

68.54%

All-time high

$1,639.00

All-time high date

2015-07-14

All-time low

$3.92

All-time low date

2026-02-23

Average true range (ATR)

$0.61

Average volume

32.3K

Beta (1Y)

2.13

Beta (2Y)

0.95

Beta (5Y)

0.22

Change from 52-week high

-56.23%

Change from 52-week low

113.78%

Change from all-time high

-99.49%

Change from all-time low

114.54%

Change from open

-1.99%

Day's gap

3.01%

Dollar volume

$218,500

High price

$8.55

Low price

$8.37

Monthly RSI

39.48

Open price

$8.55

Position in 52-week range

5.56%

Premarket change

Premarket close

$8.30

Premarket price

$8.30

Previous close

$8.30

Price vs 150-day SMA

-1.06%

Price vs 20-day SMA

-7.99%

Price vs 200-day SMA

10.09%

Price vs 50-day SMA

-8.98%

Relative volume

0.81

RSI

40.91

Sharpe ratio

0.22

Sharpe ratio (3Y)

0.4

Sharpe ratio (5Y)

0.03

Sortino ratio

0.41

Sortino ratio (3Y)

0.65

Sortino ratio (5Y)

0.09

Volume

26.1K

Weekly RSI

46.82

YTD price change

-53.51%

YTD total return

-53.51%

Metric	Value
Float	4.6M
Float percentage	46.06%
Shares change (QoQ)	6.76%
Shares change (YoY)	36.26%
Shares held by insiders	3.68%
Shares held by institutions	21.62%
Shares outstanding	10M
Short % of float	7.58%
Short % of shares	3.49%
Short ratio	6.9 days

Metric

Value

Float

4.6M

Float percentage

46.06%

Shares change (QoQ)

6.76%

Shares change (YoY)

36.26%

Shares held by insiders

3.68%

Shares held by institutions

21.62%

Shares outstanding

10M

Short % of float

7.58%

Short % of shares

3.49%

Short ratio

6.9 days

Atara Biotherapeutics, Inc. (ATRA)

Price

Financial snapshot

Fair-value bridge

Latest news · ATRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ATRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ATRA

Frequently asked questions